Combination Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma-Reply

JAMA Oncol. 2021 Mar 1;7(3):465-466. doi: 10.1001/jamaoncol.2020.7873.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anthracyclines*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Doxorubicin / adverse effects
  • Humans
  • Sarcoma* / drug therapy

Substances

  • Anthracyclines
  • Antibodies, Monoclonal, Humanized
  • Doxorubicin
  • pembrolizumab